OTCMKTS:BICX Biocorrx (BICX) Stock Price, News & Analysis $0.22 0.00 (0.00%) As of 11/3/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartEarningsNews and TrendsSEC Filings About Biocorrx Stock (OTCMKTS:BICX) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Biocorrx alerts:Sign Up Key Stats Today's Range$0.22▼$0.2250-Day Range$0.20▼$0.2552-Week Range$0.15▼$1.28Volume10 shsAverage Volume627 shsMarket Capitalization$6.71 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview BioCorRx Inc. is a healthcare company focused on solutions for individuals seeking recovery from alcohol and other substance-use disorders. Its principal offering, the BioCorRx Recovery Program, combines medical treatment with counseling, coaching, and ongoing support. The company has described the program as a non-addictive, medication-assisted recovery approach that may be delivered through participating treatment providers. BioCorRx also develops and markets nutritional and wellness products intended to support recovery and overall health. Its business model has included licensing its recovery program and related materials to treatment centers, physicians, and other qualified providers, primarily in the United States. The company is associated with Chief Executive Officer Lourdes Felix, who has been involved in the development and promotion of its addiction-recovery programs. BioCorRx was established in the late 2000s and has focused its operations on expanding access to structured recovery services through provider partnerships.AI Generated. May Contain Errors. Read More Receive BICX Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Biocorrx and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BICX Stock News HeadlinesBioCorRx Inc. Appoints Former Acting White House Drug Policy Director Richard J. Baum to Strategic Advisory BoardSeptember 10, 2026 | finance.yahoo.comBioCorRx Announces National Drug Codes (NDCs) for LUCEMYRA (lofexidine) Brand and Authorized Generic (AG) SKUs to Ensure Uninterrupted Market SupplyAugust 25, 2026 | finance.yahoo.comFinancial Legend: “Big trouble ahead …”Dr. Martin D. Weiss, founder of Weiss Ratings and a two-time Congressional witness on financial institution risk, is warning of a looming $3 trillion threat in today's financial system. He says the same ratings agency practices that preceded the 2008 crisis are repeating themselves, while regulators stay quiet about the risks.November 4 at 1:00 AM | Weiss Ratings (Ad)BioCorRx Inc.April 21, 2026 | marketwatch.comBioCorRx, Inc. Announces Issuance of U.S. Patent Supporting Its Biodegradable Naltrexone Implant TechnologyMarch 11, 2026 | finance.yahoo.comBioCorRx, Inc. Announces Initiation of Clinical Study by Majority-Owned Subsidiary BioCorRx Pharmaceuticals, Inc. Evaluating Long-Acting Naltrexone Implant With or Without ...January 15, 2026 | finance.yahoo.comBioCorRx Announces Appointment of Louis Lucido as Board ChairJanuary 6, 2026 | finance.yahoo.comBioCorRx Provides Update on OTC Markets Quotation Status and Planned Form S1 FilingDecember 24, 2025 | finance.yahoo.comSee More Headlines BICX Stock Analysis - Frequently Asked Questions How have BICX shares performed this year? Biocorrx's stock was trading at $0.2911 at the beginning of 2026. Since then, BICX shares have decreased by 24.4% and is now trading at $0.22. How were Biocorrx's earnings last quarter? Biocorrx Inc. (OTCMKTS:BICX) released its earnings results on Friday, August, 14th. The company reported ($0.03) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.05) by $0.02. The firm had revenue of $88 thousand for the quarter, compared to analyst estimates of $240 thousand. How do I buy shares of Biocorrx? Shares of BICX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Biocorrx own? Based on aggregate information from My MarketBeat watchlists, some other companies that Biocorrx investors own include Alkermes (ALKS), Fastenal (FAST), AT&T (T), Aphria (APHA), Axos Financial (AX) and AstroNova (ALOT). Company Calendar Last Earnings8/14/2026Today11/04/2026Next Earnings (Estimated)11/17/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Healthcare Providers & Services Sub-IndustryN/A Current SymbolOTCMKTS:BICX CIK1443863 Webwww.biocorrx.com Phone(714) 462-4880FaxN/AEmployees3Year Founded2008Profitability EPS (Trailing Twelve Months)($0.12) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$3.44 million Net MarginsN/A Pretax Margin-399.75% Return on EquityN/A Return on Assets-90.89% Debt Debt-to-Equity RatioN/A Current Ratio0.07 Quick Ratio0.07 Sales & Book Value Annual Sales$800 thousand Price / Sales8.39 Cash FlowN/A Price / Cash FlowN/A Book Value($0.47) per share Price / Book-0.47Miscellaneous Outstanding Shares30,520,000Free Float23,992,000Market Cap$6.71 million OptionableNot Optionable Beta0.07 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (OTCMKTS:BICX) was last updated on 11/3/2026 by MarketBeat.com Staff. From Our PartnersTrump compared today's market to 1929 not once but twicePresident Trump warned of a 1929-style depression if Democrats won control of Congress. On November 3, they di...USA Capital Gold | SponsoredI'm handing you this one freeElon Musk doesn't own the chip powering every Tesla, every Starlink dish, and every AI satellite he builds, he...Behind the Markets | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredMany investors are about to lose everythingTwenty five years ago, this analyst predicted the fiber optic boom and called Amazon before it became a househ...Porter & Company | SponsoredU.S. Army Advances 75-Year Rare Earth Deal With Nasdaq FirmThe Pentagon is moving to cut US dependence on Chinese rare earth metals, and a Nasdaq-listed company just sig...The Tomorrow Investor | SponsoredElon Musk about to bankrupt Amazon, Microsoft & Google?Jeff Brown, the former tech executive who called the rise of Bitcoin, Tesla, and Nvidia years early, is tracki...Brownstone Research | SponsoredLast call for your free 0DTE reportThe 0DTE Game Plan lays out a simple 3-step framework for trading same-day options: Plan it, profit from it, p...Profits Run | SponsoredBank of America: 'Digital Dollar Inevitable'Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...Decentralized Masters | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biocorrx Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biocorrx With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BICX Stock Alerts